Literature DB >> 21255482

New insights into the mechanisms of the interactions between doxorubicin and the ion-exchange hydrogel DC Bead™ for use in transarterial chemoembolization (TACE).

Marco Biondi1, Sabato Fusco, Andrew L Lewis, Paolo A Netti.   

Abstract

Ion-exchange microspheres (IEMs) are widely employed in controlled drug delivery of ionic drugs due to their high loading capacity and the possibility to obtain the controlled release of the loaded drug(s) at a specific site. Among IEMs, DC Bead(™) are embolic microdevices (100-300 μm diameter) designed for transarterial chemoembolization (TACE) and composed of cross-linked poly(vinyl alcohol) (PVA) hydrogel, bearing anionic sulfonate moieties on the cross-links, and able to bind cationic drugs such as doxorubicin hydrochloride (Dox). Even if DC Bead(™) were studied for their release and bulk characteristics, a thorough characterization of these devices is still lacking. In particular, the aim of this work was the determination of bound and free water, Dox distribution within the microdevices and drug-DC Bead(™) interactions, in terms of transport features within the device. Compared with previous results, different Dox radial distributions in DC Bead(™) were found, and related to bead microsctructure and ion exchange mechanism. Artifacts due to the self-quenching of Dox at high concentration were prevented and the diffusion coefficients of drug-polymer (Dox-ionic sites) evaluated in different sections of the microspheres. Furthermore, DSC results indicated that in the hydrogel either free (bulk) or bound (non-freezable) water could be found, and that no freezing-bound water was present.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21255482     DOI: 10.1163/092050610X551934

Source DB:  PubMed          Journal:  J Biomater Sci Polym Ed        ISSN: 0920-5063            Impact factor:   3.517


  11 in total

Review 1.  Locoregional drug delivery using image-guided intra-arterial drug eluting bead therapy.

Authors:  Andrew L Lewis; Matthew R Dreher
Journal:  J Control Release       Date:  2012-01-21       Impact factor: 9.776

Review 2.  Chemoembolization with DC Bead™ for the treatment of hepatocellular carcinoma: an update.

Authors:  Katerina Malagari; Emmanouil Emmanouil; Maria Pomoni; Dimitrios Kelekis
Journal:  Hepat Oncol       Date:  2014-03-20

3.  Design and characterization of a chitosan physical gel promoting wound healing in mice.

Authors:  Laura Mayol; Daniela De Stefano; Virginia Campani; Francesca De Falco; Eleonora Ferrari; Claudia Cencetti; Pietro Matricardi; Luigi Maiuri; Rosa Carnuccio; Angela Gallo; Maria Chiara Maiuri; Giuseppe De Rosa
Journal:  J Mater Sci Mater Med       Date:  2014-03-02       Impact factor: 3.896

4.  Investigation of the mechanisms governing doxorubicin and irinotecan release from drug-eluting beads: mathematical modeling and experimental verification.

Authors:  Marco Biondi; Sabato Fusco; Andrew L Lewis; Paolo A Netti
Journal:  J Mater Sci Mater Med       Date:  2013-10       Impact factor: 3.896

5.  In vitro comparative study of drug loading and delivery properties of bioresorbable microspheres and LC bead.

Authors:  Lihui Weng; Hsiang-Jer Tseng; Parinaz Rostamzadeh; Jafar Golzarian
Journal:  J Mater Sci Mater Med       Date:  2016-10-17       Impact factor: 3.896

6.  Multimodality Imaging of Ethiodized Oil-loaded Radiopaque Microspheres during Transarterial Embolization of Rabbits with VX2 Liver Tumors.

Authors:  Vania Tacher; Rafael Duran; MingDe Lin; Jae Ho Sohn; Karun V Sharma; Zhijun Wang; Julius Chapiro; Carmen Gacchina Johnson; Nikhil Bhagat; Matthew R Dreher; Dirk Schäfer; David L Woods; Andrew L Lewis; Yiqing Tang; Michael Grass; Bradford J Wood; Jean-François Geschwind
Journal:  Radiology       Date:  2015-12-16       Impact factor: 11.105

7.  Evaluation of immune-modulating drugs for use in drug-eluting microsphere transarterial embolization.

Authors:  Andrew S Mikhail; Michal Mauda-Havakuk; Ayele H Negussie; Natalie Hong; Natalie M Hawken; Camella J Carlson; Joshua W Owen; Olga Franco-Mahecha; Paul G Wakim; Andrew L Lewis; William F Pritchard; John W Karanian; Bradford J Wood
Journal:  Int J Pharm       Date:  2022-01-20       Impact factor: 6.510

8.  Sorafenib and 2,3,5-triiodobenzoic acid-loaded imageable microspheres for transarterial embolization of a liver tumor.

Authors:  Jin Woo Choi; Ju-Hwan Park; Hye Rim Cho; Jin Wook Chung; Dae-Duk Kim; Hyo-Cheol Kim; Hyun-Jong Cho
Journal:  Sci Rep       Date:  2017-04-03       Impact factor: 4.379

9.  DC BeadM1™: towards an optimal transcatheter hepatic tumour therapy.

Authors:  Andrew L Lewis; Matthew R Dreher; Vincent O'Byrne; David Grey; Marcus Caine; Anthony Dunn; Yiqing Tang; Brenda Hall; Kirk D Fowers; Carmen Gacchina Johnson; Karun V Sharma; Bradford J Wood
Journal:  J Mater Sci Mater Med       Date:  2015-12-16       Impact factor: 3.896

10.  Magnetic Driven Nanocarriers for pH-Responsive Doxorubicin Release in Cancer Therapy.

Authors:  João Nogueira; Sofia F Soares; Carlos O Amorim; João S Amaral; Cláudia Silva; Fátima Martel; Tito Trindade; Ana L Daniel-da-Silva
Journal:  Molecules       Date:  2020-01-14       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.